SCHEMBL9897170

SCHEMBL9897170

CCC(=O)NC1CCC(NC(=O)c2c(C)[nH]c3c(-c4cc(CC)ccc4OCC4CC4)ncnc23)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 3/20 0.35
HDAC1 Q13547 3/20 0.35
HDAC6 Q9UBN7 3/20 0.35
SMYD3 Q9H7B4 2/20 0.35
BRD4 O60885 3/20 0.34
HPGD P15428 2/20 0.33
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33
RIPK2 O43353 1/20 0.33
PTGES O14684 1/20 0.33
HDAC2 Q92769 1/20 0.33
GRIN1 Q05586 3/20 0.32
GRIN2B Q13224 3/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
LMNA P02545 1/20 0.32
PIK3CD O00329 1/20 0.32
RBP4 P02753 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9897226 1.00 PDE5A (0.35) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9897168 1.00 PDE5A (0.35) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9896524 0.94 SMYD3 (0.34) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9897406 0.94 SMYD3 (0.34) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9896522 0.94 SMYD3 (0.34) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9897041 0.94 SMYD3 (0.36) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL1441884 0.94 SMYD3 (0.36) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL1441879 0.94 SMYD3 (0.36) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9897147 0.93 HPGD (0.34) PDE5AHDAC1HDAC6SMYD3BRD4
SCHEMBL9897927 0.93 HPGD (0.34) PDE5AHDAC1HDAC6SMYD3BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US claimed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US claimed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US claimed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP claimed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US claimed
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US disclosed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US disclosed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US disclosed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP disclosed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE12, PDE4A PDE5A 1/4885HDAC1 493/4885HDAC6 1912/4885
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE12, PDE5A, PDE4A PDE5A 2/4885HDAC1 674/4885HDAC6 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.